Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Moderna Inc
(NQ:
MRNA
)
107.89
+3.43 (+3.28%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Moderna Inc
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Moderna Announces Supply Agreement with Gavi for up to 500 Million Doses of COVID-19 Vaccine Moderna for COVAX To Help End COVID-19 Pandemic in Lowest Income Countries
May 03, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Emergency Use Listing Granted by the World Health Organization for its COVID-19 Vaccine
April 30, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Additional Investments to Increase Global Supply for COVID-19 Vaccine to up to 3 Billion Doses in 2022
April 29, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Agreement with Sanofi for Fill/Finish Manufacturing of the Moderna COVID-19 Vaccine in the U.S.
April 26, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces New Supply Agreement with Israel for 2022
April 20, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Report First Quarter Financial Results on Thursday, May 6, 2021
April 16, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Announces Clinical Progress from its Industry-Leading mRNA Vaccine Franchise and Continues Investments to Accelerate Pipeline Development
April 14, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day
April 13, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna to Present at the 20th Annual Needham Virtual Healthcare Conference
April 09, 2021
From
Moderna, Inc.
Via
Business Wire
Moderna Highlights Publication of Antibody Persistence Data of its COVID-19 Vaccine out to 6 Months in the New England Journal of Medicine
April 07, 2021
From
Moderna, Inc.
Via
Business Wire
< Previous
1
2
...
6
7
8
9
10
11
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.